Republic Healthcare Limited provided earnings guidance for the six months ended 30 June 2020. The company announced that, based on a preliminary review of the unaudited financial and operating information of the Group for the six months ended 30 June 2020, the Group is expected to report a net loss for the Period of approximately SGD 0.5 million as compared to a net profit of approximately SGD 0.6 million for the six months ended 30 June 2019. The Group is also expected to record a decrease in revenue of approximately 11.2% from approximately SGD 6.3 million in the Corresponding Period to approximately SGD 5.6 million for the Period. Based on the preliminary review of the Group's draft financial results for the Period, the net loss for the Group is mainly attributable to (1) the outbreak of the novel coronavirus pneumonia epidemic in Singapore where the Singapore government had implemented very high safe distancing measures in place to avoid the spread of COVID-19. The implementation of the Circuit Breaker had posed operational challenges for clinics under the Group; and (2) the increase in employees benefits expenses in view of the planned upcoming expansion of clinics. As the Company is still in the process of finalizing the unaudited consolidated management accounts of the Group for the Period, the information contained in this announcement is based only on a preliminary review of the unaudited consolidated management accounts of the Group and information currently available to the Board for the Period, which have not been reviewed or audited by the Company's auditors or reviewed by the audited committee of the Company. The actual results of the Group for the Period may significantly differ from the information contained in this announcement. The Group's unaudited consolidated results for the Period are expected to be published in August 2020.